Arvinas, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ARVN Nasdaq 2834 www.arvinas.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arvinas, Inc.

Arvinas Shares Fall Amid Breast Cancer Drug Trial Update, CCO Departure - Jan 10th, 2025 7:37 pm
Arvinas Updates Guidance for First- and Second-Line Phase 3 Combination Trials with Vepdegestrant, Highlights Upcoming Milestones, and Provides Corporate Update - Jan 10th, 2025 12:00 pm
Arvinas and Pfizer’s combo therapy shows promise in breast cancer trial - Dec 11th, 2024 10:38 am
Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Clinical Benefit In Breast Cancer Patients - Dec 10th, 2024 6:23 pm
Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium - Dec 10th, 2024 2:05 pm
Why Is Arvinas, Inc. (ARVN) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Dec 4th, 2024 6:19 pm
Arvinas to Present at Piper Sandler 36th Annual Healthcare Conference - Nov 27th, 2024 12:00 pm
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 San Antonio Breast Cancer Symposium - Nov 25th, 2024 10:35 pm
Arvinas, Inc. (ARVN): This Small-Cap Stock Is Ready To Explode - Nov 19th, 2024 2:06 pm
Arvinas to Participate in Upcoming Investor Conferences - Nov 4th, 2024 12:00 pm
Arvinas Third Quarter 2024 Earnings: Beats Expectations - Nov 1st, 2024 1:38 pm
Arvinas Inc (ARVN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Promising ... - Oct 31st, 2024 7:05 am
Arvinas, Inc. (ARVN) Reports Q3 Loss, Tops Revenue Estimates - Oct 30th, 2024 12:10 pm
Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Oct 30th, 2024 11:00 am
We're Hopeful That Arvinas (NASDAQ:ARVN) Will Use Its Cash Wisely - Oct 25th, 2024 11:23 am
Arvinas (ARVN): A Small-Cap Biotech with High Growth Potential - Oct 23rd, 2024 12:44 pm
Arvinas Gives Back to Local Greater New Haven Community in Third Annual Impact Day - Oct 22nd, 2024 8:05 pm
Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024 - Oct 21st, 2024 11:00 am
Arvinas (NASDAQ:ARVN) shareholders have endured a 74% loss from investing in the stock three years ago - Sep 14th, 2024 1:28 pm
Vanguard Group Inc's Strategic Acquisition of Arvinas Inc Shares - Sep 12th, 2024 5:18 am